Yazar "Susleyici, Belgin" için listeleme
-
Association of PD-1 and PDL-1 gene polymorphisms with colorectal cancer risk and prognosis
Çevik, Mehtap; Namal, Esat; Iner-Koksal, Ulkuhan; Dinc-Sener, Nur; Karaalp, Atila; Ciftci, Cavlan; Susleyici, Belgin (Springer, 2022)Background Programmed Cell Death-1 (PD-1) together with Programmed Death Ligand 1 (PDL-1) have crucial roles in anti-tumor immune response, cancer susceptibility and prognosis. Since PD-1 and PDL-1 have been considered as ... -
The effects of SNAI1 rs6125849 gene polymorphism on metastasis and survival in colorectal cancer: Preliminary results from Turkish subjects
Cevik, Mehtap; Namal, Esat; Sener, Nur Dinc; Koksal, Ulkuhan Iner; Deliorman, Gokce; Ciftci, Cavlan; Susleyici, Belgin (Elsevier, 2021)Background: Since metastasis is one of the leading causes of high mortality in colorectal cancer, uncovering the molecular mechanisms underlying metastatic process has become important to find new treatment approaches. ... -
Investigation of DPYD, MTHFR and TYMS polymorphisms on 5-fluorouracil related toxicities in colorectal cancer
Cevik, Mehtap; Namal, Esat; Sener, Nur Dinc; Koksal, Ulkuhan Iner; Cagatay, Penbe; Deliorman, Gokce; Susleyici, Belgin (Future Medicine Ltd, 2022)Aim: To investigate the association of DPYD, MTHFR and TYMS polymorphisms on 5-fluorouracil (5-FU) related toxicities and patient survival. Materials & methods: A total of 103 colorectal cancer patients prescribed 5-FU ... -
Oral Antidiyabetik Kullanımının, Farklılaşmış 3T3-L1 Hücrelerinde Adipogenez Metabolizmasında Görev Alan VDR, SIRT1, Apelin ve FOXO1 Gen Anlatım Seviyelerine Etkileri
Giriş: Yağ doku, obezite ve insülin direnci üzerindeki sistemik etkilere aracılık eden sitokinleri salgılamaktadır. Kullanılan antidiyabetik ilaçlar, 3T3-L1 adiposit hücrelerinde metabolik farklılıklar ve gen anlatım ... -
Warfarin pharmacogenetics in patients with heart valve replacement
Bezci, Kivanc; Cevik, Mehtap; Akdeniz, Cansu Selcan; Canbolat, Ismail Polat; Yurdakul, Selen; Sunbul, Murat; Susleyici, Belgin (Elsevier, 2020)Background: Warfarin treatment is crucial to prevent thrombolytic complications after the heart valve replacement (HVR) operation. Our purpose was to investigate the prevalence of CYP2C9 *2 and *3 gene polymorphisms, which ...
